NorthWest Biotherapeutics Inc (NWBO)

[ilovetech]

Roman - The market has yet to realize the added value of EDEN in the valuation conversation. Effectively, we have two standalone businesses under the same offering. DNDN was the first Dendritic Cell based treatment approved, and we know that manufacturing caused it's demise. I can't think of a better performance than LP's execution and forethought to get manufacturing capability to this point. It's absolutely remarkable!! The nature of the undertaking coupled with the nature of developing biotech can cause people to lose sight of the marvel that's taking place before them.

ILT